We report a case of lupus presenting with focal as well as diffuse neurological deficits with intracranial and subarachnoid haemorrhages and diffuse hyperintense lesions in T2-weighted and fluid-attenuated inversion recovery images of brain magnetic resonance imaging proved by further investigation as demyelination, which completely recovered with intravenous methylprednisolone therapy. During the patient’s hospital stay there was one episode of transient hypertensive episode lasting a few hours, promptly reverting to normal with low-dose ramipril therapy. Complete neurological and radiological recovery of such diffuse leucoencephalopathy-like central nervous system lesions has been rarely reported before.
JennekensFGIKaterL. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology2002; 41: 619–630.
2.
NivedOSturfeltGLiangMHDe PabloP. The ACR nomenclature for CNS lupus revisited. Lupus2003; 12: 872–876.
3.
ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599–608.
4.
JennekensFGIKaterL. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology2002; 41: 605–618.
5.
KarassaFBIoannidisJPTouloumiG. Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM2000; 93: 169–174.
6.
SannaGBertolacciniMLMathieuA. Central nervous system lupus: a clinical approach to therapy. Lupus2003; 12: 935–942.
7.
Trevisani VF, Castro AA, Neves Neto JF, et al. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database Syst Rev 2006; 19: CD002265.
8.
KimuraMAramakiKWadaT. Reversible focal neurological deficits in systemic lupus erythematosus: report of 2 cases and review of the literature. J Neurol Sci2008; 272: 71–76.
9.
DubreuilFCabrePSmadjaD. [Acute disseminated encephalomyelitis preceding cutaneous lupus]. Rev Med Interne1998; 19: 128–130 [Article in French].
10.
MatsukawaYMizutaniTKitamuraN. Patient with both lupus anticoagulant and acute disseminated encephalomyelitis. Clin Rheumatol1996; 15: 501–503.
11.
TenembaumSChamolesNFejermanN. Acute disseminated encephalomyelitis. A long-term follow-up study of 84 pediatric patients. Neurology2002; 59: 1224–1231.
12.
GargRK. Acute disseminated encephalomyelitis. Postgrad Med J2003; 79: 11–17.
13.
MagnanoMDBushTMHerreraI. Reversible posterior leucoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum2006; 35: 396–402.
14.
PrimaveraAAudeninoDMavilioN. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis2001; 60: 534–537.
15.
MakAChanBPYehIB. Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma. Rheumatology2008; 47: 256–262.
16.
Dervisoglu E, Yegenaga I, Anik Y, et al. Diffusion magnetic resonance imaging may provide prognostic information in osmotic demyelination syndrome: report of a case. Acta Radiol 2006; 47: 208–212.
17.
ChuKKangDWKoSB. Diffusion-weighted MR findings of central pontine and extrapontine myelinolysis. Acta Neurol Scand2001; 104: 385–388.
18.
ShibataMKibeTFujimotoS. Diffuse central nervous system lupus involving white matter, basal ganglia, thalami and brainstem. Brain Dev1999; 21: 337–340.
19.
SibbittWLJrBrooksWMHaselerLJ. Spin-spin relaxation of brain tissues in systemic lupus erythematosus. A method for increasing the sensitivity of magnetic resonance imaging for neuropsychiatric lupus. Arthritis Rheum1995; 38: 810–818.
20.
SibbittWLJrBrooksWMKornfeldMHartBLBankhurstADRoldanCA. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum2010; 40: 32–52.
21.
MoritaniTShrierDANumaguchiY. Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus. Acad Radiol2001; 8: 741–753.
22.
ZivadinovRBergslandNStosicM. Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis. Neurol Res2008; 30: 816–826.
23.
BozCVeliogluSAltunayoğluVOzmenogluMEremC. Central nervous system involvement in autoimmune polyglandular syndrome. Clin Neurol Neurosurg2003; 10: 102–104.
24.
EllisSGVerutyMA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum1979; 8: 212–221.
KhalidiNAAjmaniHVargaJ. Coexisting systemic lupus erythematosus and sickle cell disease: a diagnostic and therapeutic challenge. J Clin Rheumatol2005; 11: 86–92.
30.
PashankarFDMentLRPearsonHA. Sickle cell disease complicated by post-streptococcal glomerulonephritis, cerebral haemorrhage and reversible posterior leucoencephalopathy syndrome. Pediatr Blood Cancer2008; 50: 864–866.
31.
PetzLDYamPWilkinsonLGarrattyGLubinBMentzerW. Increased IgG molecules bound to the surface of red blood cells of patients with sickle cell anemia. Blood1984; 64: 301–304.
